Stem cell therapies for injured spinal cord

• Okano Hideyuki

  Department of Physiology, Keio University School of Medicine

• Nakamura Masaya

  Department of Orthopedic Surgery, Keio University School of Medicine

• Toyama Yoshiaki

  Department of Orthopedic Surgery, Keio University School of Medicine

抄録

Although it was long thought that the damaged adult central nervous system (CNS) cannot regenerate, spinal cord injury (SCI) is now an important target in regenerative medicine. A series of studies on stem cell-based therapies for SCI has led us to believe that neural stem/progenitor cells (NSPCs) are a promising source for neural tissue replacement therapy after SCI, when applied appropriately. In this review, we summarize our previous findings on stem cell therapies for SCI and discuss the future directions of this work.

収録刊行物

• 炎症・再生

  炎症・再生 26 (1), 18-28, 2006

  一般社団法人 日本炎症・再生医学会

キーワード

• neural stem cells
• spinal cord injury
• IL-6
• chondroitin sulfate proteoglycan
• common marmoset
• human ES cells

詳細情報

• CRID: 1390282680156304256
• NII論文ID: 10018657069
• NII書誌ID: AA11508953
• DOI: 10.2492/jsir.26.18
• COI: 1:CAS:528:DC%2BD28Xis1WnsL4%3D
• ISSN: 18805795
• ISSN: 13468022
• Web Site: https://search.jamas.or.jp/link/ui/2006128735
• 本文言語コード: en
• データソース種別:
  • JaLC
  • Crossref
  • CiNii Articles
• 抄録ライセンスフラグ: 使用不可